Published by Josh White on 30th April 2024
(Sharecast News) - Poolbeg Pharma announced an exclusive 12-month option agreement with Silk Road Therapeutics on Tuesday, to potentially acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX).
URL: http://www.digitallook.com/dl/news/story/34258053/...